Clinical outcome for BRCA1 and BRCA2 mutation carriers after contralateral prophylactic mastectomy
Main Authors: | Schmidt, MK, van Sprundel, TC, Rookus, MA, Brohet, R, van Asperen, CJ, Rutgers, EJTh, Tollenaar, RAEM, van 't Veer, LJ |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2005
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233517/ |
Similar Items
-
Prophylactic mastectomy versus surveillance for the prevention of breast cancer in women's BRCA carriers
by: Francisca Honold, et al.
Published: (2018-08-01) -
The Angelina Jolie Effect in Jewish Law: Prophylactic Mastectomy and Oophorectomy in BRCA Carriers
by: Grossman, Sharon Galper
Published: (2015) -
Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis
by: Metcalfe, Kelly, et al.
Published: (2014) -
Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
by: Metcalfe, K, et al.
Published: (2011) -
Predictors that Influence Election of Contralateral Prophylactic Mastectomy among Women with Ductal Carcinoma in Situ who are BRCA-Negative
by: Elsayegh, Nisreen, et al.
Published: (2015)